Strides Arcolab to acquire remaining 43% stake in Ascent Pharmahealth - MarketLine Financial Deals

Strides Arcolab to acquire remaining 43% stake in Ascent Pharmahealth

Strides Arcolab to acquire remaining 43% stake in Ascent Pharmahealth - MarketLine Financial Deals
Strides Arcolab to acquire remaining 43% stake in Ascent Pharmahealth
Published Mar 16, 2010
3 pages — Published Mar 16, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Strides Arcolab Limited is in discussions to make an indicative proposal to acquire the remaining 43% of the ordinary share capital of Ascent Pharmahealth Limited (formerly Genepharm Australasia Limited) at AUD0.35 ($0.31) per share in cash which represents an implied enterprise value of AUD100 million ($91.35 million) for Ascent.

  
Source:
Document ID
MA21416_100318
Country
Country
Ticker
532531=IN
Ticker
APH=AU
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Strides Arcolab to acquire remaining 43% stake in Ascent Pharmahealth" Mar 16, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Strides-Arcolab-to-acquire-remaining-43-stake-in-Ascent-Pharmahealth-2052-27493>
  
APA:
MarketLine Financial Deals. (2010). Strides Arcolab to acquire remaining 43% stake in Ascent Pharmahealth Mar 16, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Strides-Arcolab-to-acquire-remaining-43-stake-in-Ascent-Pharmahealth-2052-27493>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.